Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam-Reference-Cited by-同舟云学术

Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam

Published:2023-02-14 Issue:1 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Nation Monica Larissa¹^ORCID,Manna Sam¹²³^ORCID,Tran Hau Phuc⁴,Nguyen Cattram Duong¹²,Vy Le Thi Tuong⁴,Uyen Doan Y.⁴,Phuong Tran Linh⁵,Dai Vo Thi Trang⁶,Ortika Belinda Daniela¹,Wee-Hee Ashleigh Christina¹,Beissbarth Jemima⁷,Hinds Jason⁸⁹,Bright Kathryn¹,Smith-Vaughan Heidi⁷,Nguyen Thuong Vu⁴^ORCID,Mulholland Kim¹¹⁰,Temple Beth¹¹¹,Satzke Catherine¹²³^ORCID

Affiliation:

1. Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia

2. Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia

3. Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia

4. Department of Disease Control and Prevention, Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam

5. Clinical Research Center, Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam

6. Department of Microbiology and Immunology, Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam

7. Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia

8. Institute for Infection and Immunity, St. George's University of London, London, England, United Kingdom

9. BUGS Bioscience, London Bioscience Innovation Centre, London, England, United Kingdom

10. Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, England, United Kingdom

11. Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, Northern Territory, Australia

Abstract

The pneumococcus is a major cause of mortality globally. Implementation of NPIs during the COVID-19 pandemic led to reductions in invasive pneumococcal disease in many countries.

Funder

Bill and Melinda Gates Foundation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.03615-22

Reference27 articles.

1. Streptococcus pneumoniae: transmission, colonization and invasion

2. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections

3. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

4. Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study

5. Infant Pneumococcal Carriage in Belgium Not Affected by COVID-19 Containment Measures

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-17RA promotes pathologic epithelial inflammation in a mouse model of upper respiratory influenza infection;PLOS Pathogens;2023-12-07

2. Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study;PLOS Medicine;2023-06-05

3. A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age;Vaccine;2023-05